All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Cambridge researchers test first human vaccine designed entirely by artificial intelligence

By

James Gallagher

24d ago· 7 min readenNews

Summary

Researchers at the University of Cambridge have developed what they describe as a 'world-first' vaccine whose key component was designed entirely by artificial intelligence and then trialled in humans. The vaccine targets all coronaviruses, including all COVID-19 variants and animal viruses with pandemic potential. This marks the first time an AI-designed vaccine component has reached human trials, representing a significant milestone in vaccine development and pandemic preparedness.

Source

bskyCambridge researchers test first human vaccine designed entirely by artificial intelligenceow.ly

Key quotes

· 3 pulled
Artificial intelligence has been used to develop a 'fundamentally new' type of vaccine that could protect against large swathes of viruses and prevent pandemics, say researchers.
The team at the University of Cambridge say it is the first time a vaccine's key component has been designed entirely by AI and then trialled in people.
The vaccine was engineered to work on all coronaviruses which would include all Covid variants as well as viruses that currently infect animals yet have the potential to start the next pandemic.
Snippet from the RSS feed
Cambridge scientists say they have, for the first time, tested a vaccine designed by AI.

You might also wanna read

Why COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes

This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine ti

clinicaltrialsabundance.blog·4d ago

Why COVID-19 vaccines were developed in record time: funding, prior research, and parallel processes

This article explains why COVID-19 vaccines were developed in record time — roughly 11 months — compared to the typical 8-12 year vaccine ti

clinicaltrialsabundance.blog·4d ago

Stanford Researchers Develop Nasal Spray Vaccine for Universal Protection Against Respiratory Illnesses

Stanford University researchers have developed a nasal spray vaccine that could provide universal protection against all coughs, colds, flus

bbc.com·4mo ago

Stanford Researchers Develop Universal Vaccine Formula Protecting Mice Against Respiratory Viruses, Bacteria, and Allergens

Stanford Medicine researchers have developed a universal vaccine formula that protects mice against a wide range of respiratory viruses, bac

med.stanford.edu·3mo ago

The AI Adaptation Challenge: Lessons from the Pandemic's Early Days

The author draws a parallel between the early days of the COVID-19 pandemic (March 2020 in Helsinki) and the current state of AI development

wordsofwhatcouldbe.substack.com·4d ago

Scientists Develop Universal Cancer Vaccine Using mRNA Technology

Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer,

newatlas.com·11mo ago

AI Safety Researchers at Anthropic Work to Prevent Potential Societal Harms from Advanced AI Systems

The article focuses on Deep Ganguli, a research director at Stanford Institute for Human-Centered AI, who became concerned about the rapid a

The Verge·7mo ago

Comments

Sign in to join the conversation.

No comments yet. Be the first.